The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I trial of cabozantinib (XL184) and gemcitabine in advanced pancreatic cancer.
 
David Bing Zhen
No Relationships to Disclose
 
Kent A. Griffith
No Relationships to Disclose
 
Joshua Michael Ruch
No Relationships to Disclose
 
Meredith Morgan
No Relationships to Disclose
 
Edward Jae-hoon Kim
Honoraria - Guardant Health; Pharmacyclics
Consulting or Advisory Role - Bayer; Guardant Health; Momenta Pharmaceuticals; Pharmacyclics
Speakers' Bureau - Guardant Health
Research Funding - Celgene (Inst); OncoMed (Inst)
 
Vaibhav Sahai
No Relationships to Disclose
 
Diane M. Simeone
No Relationships to Disclose
 
Mark Zalupski
No Relationships to Disclose